This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ottenwalder, B. Articles by Gotz, F. Search for Related Content PubMed PubMed Citation Articles by Ottenwalder, B. Articles by Gotz, F. Agricola Articles by Ottenwalder, B. Articles by Gotz, F.

 Previous Article  |  Next Article 

Appl. Environ. Microbiol., 11 1995, 3894-3903, Vol 61, No. 11
Copyright © 1995, American Society for Microbiology

Isolation and characterization of genetically engineered gallidermin and epidermin analogs

B Ottenwalder, T Kupke, S Brecht, V Gnau, J Metzger, G Jung and F Gotz
Mikrobielle Genetik, Universitat Tubingen, Germany.

Gallidermin (Gdm) and epidermin (Epi) are highly homologous tetracyclic polypeptide antibiotics that are ribosomally synthesized by a Staphylococcus gallinarum strain and a Staphylococcus epidermidis strain, respectively. These antibiotics are secreted into media and are distinguished by the presence of the unusual amino acids lanthionine, 3- methyllanthionine, didehydrobutyrine, and S-(2-aminovinyl)-D-cysteine, which are formed by posttranslational modification. To study the substrate specificities of the modifying enzymes and to obtain variants that exhibit altered or new biological activities, we changed certain amino acids by performing site-specific mutagenesis with the Gdm and Epi structural genes (gdmA and epiA, respectively). S. epidermidis Tu3298/EMS6, an epiA mutant of the Epi-producing strain, was used as the expression host. This mutant synthesized Epi, Gdm, or analogs of these antibiotics when the appropriate genes were introduced on a plasmid. No Epi or Gdm analogs were isolated from the supernatant when (i) hydroxyamino acids involved in thioether amino acid formation were replaced by nonhydroxyamino acids (S3N and S19A); (ii) C residues involved in thioether bridging were deleted (delta C21, C22 and delta C22); or (iii) a ring amino acid was replaced by an amino acid having a completely different character (G10E and Y20G). A strong decrease in production was observed when S residues involved in thioether amino acid formation were replaced by T residues (S16T and S19T). A number of conservative changes at positions 6, 12, and 14 on the Gdm backbone were tolerated and led to analogs that had altered biological properties, such as enhanced antimicrobial activity (L6V) or a remarkable resistance to proteolytic degradation (A12L and Dhb14P). The T14S substitution led to simultaneous production of two Gdm species formed by incomplete posttranslational modification (dehydration) of the S-14 residue. The fully modified Dhb14Dha analog exhibited antimicrobial activity similar to that of Gdm, whereas the Dhb14S analog was less active. Both peptides were more sensitive to tryptic cleavage than Gdm was.

This article has been cited by other articles:

• Valsesia, G., Medaglia, G., Held, M., Minas, W., Panke, S. (2007). Circumventing the Effect of Product Toxicity: Development of a Novel Two-Stage Production Process for the Lantibiotic Gallidermin. Appl. Environ. Microbiol. 73: 1635-1645 [Abstract] [Full Text]  
• McClerren, A. L., Cooper, L. E., Quan, C., Thomas, P. M., Kelleher, N. L., van der Donk, W. A. (2006). Discovery and in vitro biosynthesis of haloduracin, a two-component lantibiotic. Proc. Natl. Acad. Sci. USA 103: 17243-17248 [Abstract] [Full Text]  
• Bonelli, R. R., Schneider, T., Sahl, H.-G., Wiedemann, I. (2006). Insights into In Vivo Activities of Lantibiotics from Gallidermin and Epidermin Mode-of-Action Studies.. Antimicrob. Agents Chemother. 50: 1449-1457 [Abstract] [Full Text]  
• Szekat, C., Jack, R. W., Skutlarek, D., Farber, H., Bierbaum, G. (2003). Construction of an Expression System for Site-Directed Mutagenesis of the Lantibiotic Mersacidin. Appl. Environ. Microbiol. 69: 3777-3783 [Abstract] [Full Text]  
• Hille, M., Kies, S., Götz, F., Peschel, A. (2001). Dual Role of GdmH in Producer Immunity and Secretion of the Staphylococcal Lantibiotics Gallidermin and Epidermin. Appl. Environ. Microbiol. 67: 1380-1383 [Abstract] [Full Text]  
• Chen, P., Novak, J., Kirk, M., Barnes, S., Qi, F., Caufield, P. W. (1998). Structure-Activity Study of the Lantibiotic Mutacin II from Streptococcus mutans T8 by a Gene Replacement Strategy. Appl. Environ. Microbiol. 64: 2335-2340 [Abstract] [Full Text]  
• Wiedemann, I., Breukink, E., van Kraaij, C., Kuipers, O. P., Bierbaum, G., de Kruijff, B., Sahl, H.-G. (2001). Specific Binding of Nisin to the Peptidoglycan Precursor Lipid II Combines Pore Formation and Inhibition of Cell Wall Biosynthesis for Potent Antibiotic Activity. J. Biol. Chem. 276: 1772-1779 [Abstract] [Full Text]